Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The Objective of this study is to compare the relative bioavailability of pantoprazole sodium
40 mg delayed-released tablets (manufactured by TEVA Pharmaceutical Industries,Ltd. and
distributed by TEVA Pharmaceuticals USA)with that of PROTONIX® 40mg delayed-released tablets
(Wyeth- Ayerst) in Healthy, adult, non-smoking subjects under non- fasting conditions.